What is Natera Inc (NTRA) stock price today?

Natera Inc (NTRA) currently trades at $194.75 per share. The stock has a market capitalization of $27.81B and a P/E ratio of —x.

Is NTRA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Natera Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is —.

What is Natera Inc's revenue and earnings?

Natera Inc has trailing twelve-month (TTM) revenue of $2.31B with profit margins of -9.03%. Earnings per share (EPS) is $-1.52.

Is Natera Inc financially healthy?

Natera Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of — places it in the —.

NTRA

Natera Inc

NASDAQ: NTRA · HEALTHCARE · DIAGNOSTICS & RESEARCH

$194.75

-2.71% today

Updated 2026-04-29

Market cap

$27.81B

P/E ratio

—

P/S ratio

12.06x

EPS (TTM)

$-1.52

Dividend yield

—

52W range

$132 – $256

Volume

1.3M

Market cap

$27.81B

P/E ratio

—

P/S ratio

12.06x

EPS (TTM)

$-1.52

Dividend yield

—

52W range

$132 – $256

Volume

1.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

8.0

Growth

6.5

Quality

2.0

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$258.00

+32.48%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

5 Strong Buy12 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $37.82M — positive

+ Revenue growth 39.80% QoQ

Risks

- Thin margins at -9.03%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM	2026 (E)
Revenue	$820.22M	$1.08B	$1.70B	$2.31B	$2.31B	$2.7B
Net income	$-547.80M	$-434.80M	$-190.43M	$-208.16M	$47.26M	—
EPS	—	—	—	—	$-1.52	$-1.90
Free cash flow	$-479.20M	$-286.15M	$69.24M	$109.11M	$37.82M	—
Profit margin	-66.79%	-40.16%	-11.22%	-9.03%	-9.03%	—

Recent insider activity

Date	Insider	Type	Shares	Price
2029-06-23	BROPHY, MICHAEL BURKES	Sale	12,500	—
2029-06-08	BROPHY, MICHAEL BURKES	Sale	25,000	—
2026-04-17	SHEENA, JONATHAN	Sale	750	$199.59

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NTRA	$27.81B	31	8.0	2.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Natera Inc trades at $194.75. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $2.31B. with profit margins at -9.03%.

Frequently asked questions

What is Natera Inc's stock price?

Natera Inc (NTRA) trades at $194.75.

Is Natera Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Natera Inc (NTRA)?

The analyst target price is $258.00, representing +32.5% upside from the current price of $194.75.

What is Natera Inc's revenue?

TTM revenue is $2.31B.

Piotroski F-Score?

4/9 — moderate financial health.

Company info

SectorHEALTHCARE

IndustryDIAGNOSTICS & RESEARCH

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio12.06x

ROE-14.30%

Beta1.68

50D MA$202.37

200D MA$196.21

Shares out0.14B

Float0.14B

Short ratio—

Avg volume1.3M

Performance

1 week-4.42%

1 month-4.16%

3 months-15.74%

YTD-14.99%

1 year—

3 years—

5 years—

Compare

NTRA vs LLY →NTRA vs JNJ →NTRA vs ABBV →Stock screener →